Nephrology Dialysis Transplantation

Papers
(The H4-Index of Nephrology Dialysis Transplantation is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis173
Functional adaptation after kidney tissue removal in patients is associated with increased plasma atrial natriuretic peptide concentration120
Erratum to: FC041 tubular epithelial cell polyploidy is essential to survive AKI but contributes to CKD progression100
Correction to: CKD therapy to improve outcomes of immune-mediated glomerular diseases87
MO380: Bio-Conductivity Measurement for Electrical Impedance Tomography (EIT) in Chronic Kidney Disease—A Non-Invasive and Portable Monitoring Approach78
Phosphorus balance calculator: an individualized tool for treatment of hyperphosphatemia in hemodialysis patients74
Anti-C1Q monitoring predicts relapses of lupus nephritis72
Immunoengineering for autoimmune-kidney disease72
Non-crystalline light chain proximal tubulopathy, a morphologically protean entity69
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications64
#2550 Micro(nano)plastics in human urine: a surprising contrast between Chongqing's urban and rural regions59
Key enzyme in charge of ketone reabsorption of renal tubular SMCT1 may be a new target in diabetic kidney disease59
Cognitive deficits associate with cerebral hypoxia during hemodialysis57
Intravenous methylprednisolone for nephrotic syndrome with minimal change lesions: a randomized controlled trial55
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy53
#2396 The potential of human-derived macrophages to study autosomal dominant polycystic kidney disease (ADPKD)53
MO1005: Analysis of Expression of Immune System Genes that are Responsible for Activation and Inhibition of T-Cell Immune Response in Renal Transplant Recipients after Extracorporeal Photochemotherapy51
#1237 Management of dyslipidaemia with evolocumab in kidney transplant recipients51
Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI51
#3055 Replacement of tunneled cuffed hemodialysis catheters on coated guidewire: a strategic approach to treat CVC-related infections48
#1048 Why are felids at such a high risk of chronic kidney disease?48
MO197: Change in the Level Of NFKBP65 Gene Expression in the Myocardium and Kidneys of Wistar Rats and Spontaneously Hypertensive Rats (SHR) That Received Diet Rich in NACL47
#4264 PERITONEAL DIALYSIS AFTER FAILED KIDNEY TRANSPLANT: A SUITABLE OPTION44
FC077: Cystatin C Testing Improves Risk Stratification Associated with Chronic Kidney Disease Without Adopting Age-Adapted Diagnostic Thresholds: A UK Biobank Study44
FC029: A Multivariate Model Identifies Genotype, Hypertension and Kidney Length as Independent Baseline Predictors of Disease Progression in a Longitudinal Autosomal Dominant Polycystic Kidney Disease43
#606 Impact of real-world off-label dose of apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease41
#2387 Case study of a patient with gouty nephropathy treated with immunosorbent therapy41
MO227: Anca-Associated Vasculitis Following Pfizer-Biontech COVID-19 Vaccine: True Association or Circumstantial?41
#802 CENSUS-EU: a cross-sectional, study to assess the prevalence and burden of chronic kidney disease-associated pruritus in Europe40
#4176 ROLE OF KIDNEY FUNCTION ON NRF2 MRNA LEVELS IN TYPE-2 DIABETES40
Measuring quality of life in trials including patients on haemodialysis: methodological issues surrounding the use of the Kidney Disease Quality of Life Questionnaire39
#2984 SLE associated fibrillary glomerulonephritis vs SLE nephritis with fibrils: can a straightforward distinction always be made?38
#3140 Investigating the impact of Anti-IL5 therapy in eosinophilic granulomatosis with polyangiitis (EGPA): a three year longitudinal perspective38
#675 Application of ANCA-associated vasculitis Histopathological Classification and Renal Risk Score for prediction of end-stage kidney disease37
#6120 MIRNA PROFILING OF URINARY EXTRACELLULAR VESICLES (EVS) IN TBMN AND CFHR5 NEPHROPATHY FOR THE IDENTIFICATION OF NOVEL DISEASE BIOMARKERS37
#3968 DIFFERENCES IN MENTAL HEALTH STATUS DURING COVID-19 PANDEMIC BETWEEN IN-CENTER HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS36
0.80241918563843